"This collaboration will further solidify Biose's position as the world leading CDMO within the LBP space"
By integrating BactoBox® into their manufacturing, Biose is setting a new industrial standard for microbial enumeration. Rapid viable cell counts in process and release testing help accelerate the path from clinical trials to market authorization for their innovative live biotherapeutics.
Biose Industrie, a leading CDMO specializing in live biotherapeutic products (LBPs), relies on BactoBox® for process development and production. Conducting thousands of measurements annually, they ensure high-quality bacterial cultivation with greater consistency and precision, optimizing biotherapeutic outcomes.